Christin Jaye Eaton

Christin Jaye Eaton uses strategic insight and translates scientific evidence to shape the defense in drug and medical device product liability cases. She also has represented clients in consumer fraud class actions and environmental liability cases.

View the full bio for Christin Jaye Eaton at the Faegre Drinker website.

Articles by Christin Jaye Eaton:


Courts Are Citing the Rule 702 Amendments – And Litigants Should, Too

Share

Though the pending amendments to Federal Rule of Evidence 702 have not taken effect officially yet, courts already have begun to cite them. Early signs indicate the potential that, consistent with the comments by the Advisory Committee on Evidence Rules, district courts will be asked to conduct more consistently rigorous gatekeeping for expert opinions offered in their courtrooms, and will be supported when they do.  Litigants can help usher in this change by citing the amendments themselves, following the pattern of courts that have been doing so.

The Advisory Committee unanimously approved the pending amendments to Rule 702 on April 30, 2021.  On May 6, 2022, following a comment period, the Committee issued a report reflecting public comments received. In October 2022, the Committee presented the amendments to the United States Supreme Court. On April 24, 2023, the Court sent revisions to Congress. Per 28 U.S.C. § 2074(a), the revisions will take effect on December 1, 2023, unless a law is passed otherwise.

Continue reading “Courts Are Citing the Rule 702 Amendments – And Litigants Should, Too”